G. Lyrakos

1460 – Translation and validation study of the subjective happiness scale (shs) in greek general population, diabetes mellitus and patients with emotional disorders

Introduction The SHS is a brief four-item measure of global subjective happiness rated on a Likert scale from 1 (strongly disagree) to 7 (strongly agree). SHS is suited for different age, occupational, linguistic, and cultural groups, is easy to implement and its short form possesses measurement accuracy. Objectives To test the psychometric properties of SHS. Aims To validate an easy to use and valid measurement, for primary care and during treatment assessment in psychiatric patients with emotional disorder(PPED) and general population (GP) in Greece. Methods Translation was performed using the multiple forward and backward translation protocol. Life orientation test (GrLOT-R), Depression anxiety stress scale (DASS) and Satisfaction with life Scale (SWLS), was also administered to check construct validity of SWLS. Results 856 adults participated, 218 (25.5%) males, 638 (74.5%) females. The total scale of the SWLS had a coefficient alpha of .756. Item - total correlations where from .223-.735. Factor analysis has supported a unidimensional model with 1 factor explaining 59.4% of the total variance. Mean scores differed significantly between GP (M=18.4±4.4) and PPED (M=15.2±4.2) (Mean differences=4.622 p Conclusions The results of the current validation study suggest that the Greek translation of the SHS is both reliable and valid, with good construct and discriminant validity and psychometric properties close to those reported in the international literature.

EPA-1592 - Factors affecting well being in patients with thalassemia major

Introduction Subjective well-being(SWB) is the scientific name for how people evaluate their lives, and since Thalassemia is an inherited blood disorder that requires lifelong adherence to a complicated and burdensome medical regimen, SWB could be easily underevaluated. Objectives To measure the impact of SWB in adult patients with thalassemia. Aims To explore possible demographic, physical, and psychosocial correlates in SWB. Methods 117 patients(23-60 years old, Mean age=37.2±9.3; 73% females) took part in the study. Satisfaction with Life Scale(SWLS-Ed Diener) was used for SWB, along with SF12 for health related quality of life, Depression Anxiety Stress Scale (DASS), life orientation test(GrLOT-R) for dispositional optimism and a questionnaire about sociodemographic characteristics. Statistical analysis was performed with SPSS 21. Results 16.8% of patients were substantially to extremely dissatisfied with their lives(SWLS=5-14). 16.4% were slightly below average(SWLS=15-19), 19.8% had an average score (SWLS=20-24) and the rest had a high(29.8%-25-29) and very high score(17.2%-30-35) respectively. There was a significant difference between males(M=20±7) and females(M=22.8±7.2)(t=-1.906-p=0.05). Multivariate analysis revealed that optimism(beta=-.403), stress(beta=-.415), spouse existence(beta=.155), and gender(beta=.228), explained 56.4% of the variance in SWB(adjusted R2=.564-p=0.026). Age, SF12, depression, anxiety and education had a Non Significant effect in the model. Conclusions Given these findings, almost half of thalassemia patients have average to low life satisfaction, something which implies that they are sometimes not functioning well because their unhappiness serves as a distraction. Talking to a psychologist or psychiatrist can often help the patient get moving in the right direction, although positive change will be up the person

The introduction of psychotherapy in psychiatric outpatients in the last four years in a Greek hospital

Introduction The use of psychotherapy is an important part of treating psychiatric disorders, in combination with medication taking. However, despite its importance, psychotherapy is still underused from individuals with psychiatric problems in Greece. Objectives To examine the use of psychotherapy, among psychiatric outpatients, in the last four years. Aims To investigate whether there are differences in the use of psychotherapy, in combination with medications, to treat psychiatric disorders, from 2012 to 2015. Methods In this study participated 5,551 patients, 2,760 males (49.7%) and 2,791 females (50.3%). The mean age was 45.54. Convenience sampling method was used and participants were recruited from the General Hospital of Nikaia, ‘Ag. Panteleimon’, in Athens, Greece, from 01/01/2012 to 31/12/2015. SPSS software was used to analyse the data. Results There were significant differences between the four years (2012–2015) with regard to the use of psychotherapy, in combination with medications, from psychiatric patients as χ2 (21): 753.057, P Conclusions There was an increase in the use of psychotherapy, in combination with medication taking, during the four last years, from 2012–2015. However, the percentage of patients undertaking both psychotherapy and taking medications is still low. This has important clinical implications as the use of psychotherapy plays a significant role in achieving optimal health outcomes of psychiatric patients.

Gender differences in external factors affecting psychiatric visits in a Greek hospital

Introduction According to previous literature, there are important differences, based on gender, on the external factors that affect psychiatric visits of individuals. Females are, in general, more likely to report being affected by family and emotional issues whilst men are less likely to do so. Objectives To examine gender differences in external factors affecting psychiatric visits. Aims To investigate whether females report different external factors, which impact on the decision to visit a psychiatrist, compared to males. Methods In this study, there were 1205 participants, out of them 685 were males (56.8%) and 520 females (43.2%). The mean age was 45.54. Convenience sampling method was used and participants were recruited from the general hospital of Nikaia, “Ag. Panteleimon”, in Athens, Greece, from 01/01/2012 to 31/12/2015. The data were analysed through the SPSS software. Results There were significant gender differences in external factors reported for psychiatric visits, as Chi 2 (8): 185.608, P Conclusions There are significant differences in the external factors affecting psychiatric visits between men and women. Further investigating such differences could help us better understand the reasons affecting the individuals’ decision to seek psychiatric help.

EPA-1594 - Regression model for subjective well being in patients with diabetes mellitus

Introduction Subjective well being (SWB) is really an umbrella term, that includes several different components and these components are somewhat independent, while Diabetes Mellitus (DM) is a chronic condition affected by many biopsychosocial factors. Objectives To measure the impact of SWB in adult patients with DM Aims To explore possible demographic, physical, and psychosocial correlates in SWB. Methods 293 DM patients(115(39.2%) males/178(60.8%) females), in two outpatients’ clinics in Athens-Greece took part in the study. Satisfaction with Life Scale(SWLS) was used for SWB, along with SF12 for health related quality of life Depression Anxiety Stress Scale(DASS), Life Orientation Test(GrLOT-R) for dispositional optimism and a questionnaire about sociodemographic characteristics. Statistical analysis was performed with SPSS 21. Results internal Almost half of the patients(54.5%) scored below average( Conclusions Our results indicates that SWB is affected equally from biological, psychological and societal variables, giving strong evidence to the biopsychosocial model of subjective health and suggests that multidisciplinary treatment with psychological screening should be applied in these patients in order to help and motivate them feel better.

EPA-0849 – Factors affecting compliance with therapy in psychiatric inpatients during treatment

Introduction Schizophrenia and psychotic disorders represent psychiatric disease patterns characterized by great impairment due to disease severity with a great effect in patients health related quality of life, which still remain a challenge in everyday clinical practice. Aim To investigate group differences in health related quality of life(HRQoL) in patients with psychosis during in hospital treatment. Methods 174 inpatients in a psychiatric ward in Athens-Greece participated in the study. 120(69%) were males and 54(31%) females. Of them, 0(11.5%) had bipolar disorder(BD), 126(72.4%) psychosis and depression(PD) and 28(16.1%) comorbit alcohol addiction(PAA). Patients filled a battery with tests of HrQoL, psychotic symptoms, negative motions, optimism, self-esteem, happiness and life-satisfaction. Stepwise regression models were used to determine the best predictors of compliance with SPSS. Results There were a statistical significant difference in compliance between BD and PAA(good compliance 100%) and PD(good compliance 66.7%)(x2=21.09p=.001). Multivariate analysis revealed that good reaction to treatment(beta=−.736), atypical antipsychotics(beta=− .312), antidepressants(beta=−.270), days of hospitalization(beta=.203), bipolar disorder(beta=.199), sleeping pills(beta=.169) and stabilizers(beta=−.188) explained 74.5% of the variance in compliance(adjusted R2=.745 p Conclusions It seems that depression comorbidity is an effective factor affecting therapy compliance in psychosis, with days staying in hospital for treatment. Also if the patient is prior to the therapy happy with his life complies better with the pharmacological approach that was used during the days of treatment.

1467 – Symptoms of depression, anxiety and stress in patients with thalassemia in a greek transfusion center

Introduction Thalassemia is an inherited blood disorder that requires lifelong adherence to a complicated and burdensome medical regimen which could potentially impact emotional functioning of patients. Objectives To assess the prevalence of depression, anxiety and stress symptoms in adult patients with thalassemia. Aims To explore possible demographic, medical, and psychosocial correlates of these symptoms. Methods 117 patients (19-61 years old, M age = 37.2Plusmn;9.3; 63% female) took part in the study. Depression, anxiety stress scale (DASS) was used along with SF12 for health related quality of life and a questionnaire about sociodemographic characteristics. Statistical analysis was performed with SPSS 16. Results Severe depressive symptoms were found in 17 patients (15%), anxiety symptoms in 11(9.6%) and stress symptoms in 35(30.2%). Sex, age, education, marital status and income had no significant correlation with anxiety and stress. In depression there was a significant difference between single and married patients (x2=6.990 p Conclusions Given these findings, regular screening for anxiety stress and depression symptoms could help to identify at-risk patients to provide them with appropriate psychological support with the goal of improving emotional health.

1475 – Chelation therapy impact and its correlation with the psychological parameters in patients with thalassaemia

Introduction Iron Chelation treatment (ICT) in beta-thalassemia major (beta-TM) patients undergoing blood transfusions can cause low satisfaction, low compliance, with possible negative consequences on treatment success, patients’ wellbeing, and costs. Aims The purpose was to estimate the existing correlation between the Chelation therapy factor of the Specific Thalassaemia Quality of life instrument (STQOLI) and certain psychological assessments. Method The Chelation impact scale, of the Specific Thalassaemia Quality of life instrument (STQOLI), along with the Depression Anxiety Stress Scale (DASS) and the Satisfaction with Life Scale, were administered to 70 patients with thalassaemia Major on regular blood transfusion, registered with Thalassemia unit at General Hospital of Nikaia Greece. Results Statistical analysis revealed that Chelation impact in health related quality of life in patients with thalassaemia has a significant and negative correlation with depression (r=-.325 p Conclusion The better quality of life in the Chelation therapy factor a patient has the less anxious and depressed is feeling. Thalassaemia has a negative impact on emotional, social and well being in thalassaemia patients. Continuing support for better Chelation quality should be given to these patients. More understanding and support especially from health authorities, and the society is essential to enhance their quality of life.